Long-term outcomes after previable pPROM: implications for counselling at the limit of viability

Agnes Grill1, Renate Fuiko1, Raphaela Pichler1

  • 1Division of Neonatology, Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.

Insights

Infants born after previable preterm prelabour rupture of membranes (pPROM) before 23 weeks show good neurodevelopmental outcomes. Neonatal morbidity, not rupture timing, impacts long-term results, guiding individualized counseling.

Area of Science:

  • Neonatalogy
  • Perinatology
  • Developmental Pediatrics

Background:

  • Previable preterm prelabour rupture of membranes (pPROM) before 23 weeks' gestation carries high mortality and neurodevelopmental risks.
  • Limited follow-up data exist, and the impact of gestational age at rupture and latency on long-term neurodevelopment is unclear.

Purpose of the Study:

  • To provide institution-specific, contemporary long-term outcome data for counseling after pPROM.
  • To improve understanding of neurodevelopmental outcomes in infants born after pPROM < 23 weeks' gestation.

Main Methods:

  • Retrospective cohort study of infants with pPROM < 23 weeks' gestation receiving active neonatal care (2009-2022).
  • Neurodevelopmental assessment at 24-36 months' corrected age using Bayley-III scales.
  • Multivariable analysis to identify factors associated with outcome.

Main Results:

  • 72.6% of survivors had favorable neurodevelopment (no moderate/severe impairment).
  • Gestational age at rupture and latency duration were not significantly associated with outcome.
  • Neonatal morbidity burden was independently associated with poorer neurodevelopmental outcomes (OR 0.39).

Conclusions:

  • A substantial proportion of survivors after pPROM < 23 weeks achieve favorable neurodevelopment.
  • Neonatal morbidity, rather than antenatal factors like rupture timing, is key for long-term prognosis.
  • Findings support individualized counseling considering both antenatal and postnatal factors.

Related Concept Videos

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...